These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 8200042)
1. Human peripheral gamma delta T cells are stimulated by Daudi Burkitt's lymphoma and not by any other Burkitt's lymphoma tested. Kaur I; de Jong J; Schell K; Hank J; Fisch P; Sondel PM Cell Immunol; 1994 Jun; 156(1):54-61. PubMed ID: 8200042 [TBL] [Abstract][Full Text] [Related]
2. Human V gamma 9-V delta 2 T cell receptor-gamma delta lymphocytes show specificity to Daudi Burkitt's lymphoma cells. Sturm E; Braakman E; Fisch P; Vreugdenhil RJ; Sondel P; Bolhuis RL J Immunol; 1990 Nov; 145(10):3202-8. PubMed ID: 2146317 [TBL] [Abstract][Full Text] [Related]
3. MHC-unrestricted cytotoxic and proliferative responses of two distinct human gamma/delta T cell subsets to Daudi cells. Fisch P; Oettel K; Fudim N; Surfus JE; Malkovsky M; Sondel PM J Immunol; 1992 Apr; 148(8):2315-23. PubMed ID: 1532810 [TBL] [Abstract][Full Text] [Related]
4. Activation of human gamma delta T cells by Mycobacterium tuberculosis and Daudi lymphoma cells: differential regulatory effect of IL-10 and IL-12. Marx S; Wesch D; Kabelitz D J Immunol; 1997 Mar; 158(6):2842-8. PubMed ID: 9058820 [TBL] [Abstract][Full Text] [Related]
5. Close correlation between Daudi and mycobacterial antigen recognition by human gamma delta T cells and expression of V9JPC1 gamma/V2DJC delta-encoded T cell receptors. Davodeau F; Peyrat MA; Hallet MM; Gaschet J; Houde I; Vivien R; Vie H; Bonneville M J Immunol; 1993 Aug; 151(3):1214-23. PubMed ID: 8393042 [TBL] [Abstract][Full Text] [Related]
6. Requirement for CD4+ T cells in the gammadelta T cell proliferative response to Daudi Burkitt's lymphoma. Burns J; Lobo S; Bartholomew B Cell Immunol; 1996 Nov; 174(1):19-24. PubMed ID: 8929450 [TBL] [Abstract][Full Text] [Related]
7. V delta 1+ subset of human gamma delta T cells responds to ligands expressed by EBV-infected Burkitt lymphoma cells and transformed B lymphocytes. Häcker G; Kromer S; Falk M; Heeg K; Wagner H; Pfeffer K J Immunol; 1992 Dec; 149(12):3984-9. PubMed ID: 1334108 [TBL] [Abstract][Full Text] [Related]
8. Antilymphoma activity of human gamma delta T-cells in mice with severe combined immune deficiency. Malkovska V; Cigel FK; Armstrong N; Storer BE; Hong R Cancer Res; 1992 Oct; 52(20):5610-6. PubMed ID: 1394184 [TBL] [Abstract][Full Text] [Related]
13. Human intestinal V delta 1+ T cells obtained from patients with colon cancer respond exclusively to SEB but not to SEA. Maeurer M; Zitvogel L; Elder E; Storkus WJ; Lotze MT Nat Immun; 1995 Apr; 14(4):188-97. PubMed ID: 8696008 [TBL] [Abstract][Full Text] [Related]
14. Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunity. Fisch P; Meuer E; Pende D; Rothenfusser S; Viale O; Kock S; Ferrone S; Fradelizi D; Klein G; Moretta L; Rammensee HG; Boon T; Coulie P; van der Bruggen P Eur J Immunol; 1997 Dec; 27(12):3368-79. PubMed ID: 9464825 [TBL] [Abstract][Full Text] [Related]
15. Differentiation of resting human peripheral blood gamma delta T cells toward Th1- or Th2-phenotype. Wesch D; Glatzel A; Kabelitz D Cell Immunol; 2001 Sep; 212(2):110-7. PubMed ID: 11748927 [TBL] [Abstract][Full Text] [Related]
16. Increased frequency of gamma delta T cells in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Reactivity, cytotoxicity, and T cell receptor V gene rearrangements. Stinissen P; Vandevyver C; Medaer R; Vandegaer L; Nies J; Tuyls L; Hafler DA; Raus J; Zhang J J Immunol; 1995 May; 154(9):4883-94. PubMed ID: 7722338 [TBL] [Abstract][Full Text] [Related]
17. Peripheral V gamma 9/V delta 2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1-infected persons. Poccia F; Boullier S; Lecoeur H; Cochet M; Poquet Y; Colizzi V; Fournie JJ; Gougeon ML J Immunol; 1996 Jul; 157(1):449-61. PubMed ID: 8683151 [TBL] [Abstract][Full Text] [Related]
18. Recognition by human Vgamma9/Vdelta2 T cells of melanoma cells upon fusion with Daudi cells. Viale O; van der Bruggen P; Meuer E; Kunzmann R; Kohler H; Mertelsmann R; Boon T; Fisch P Immunogenetics; 1996; 45(1):27-34. PubMed ID: 8881034 [TBL] [Abstract][Full Text] [Related]
19. Daudi lymphoma killing triggers the programmed death of cytotoxic V gamma 9/V delta 2 T lymphocytes. Ferrarini M; Heltai S; Toninelli E; Sabbadini MG; Pellicciari C; Manfredi AA J Immunol; 1995 Apr; 154(8):3704-12. PubMed ID: 7706713 [TBL] [Abstract][Full Text] [Related]
20. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies. Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]